Tatebayashi

Daiichi Sankyo Chemical Pharma (DSCP) is a specialized manufacturing subsidiary of the Daiichi Sankyo Group, primarily focused on the production of active pharmaceutical ingredients (APIs) and intermediates. The company operates a major facility in Tatebayashi, Gunma Prefecture, which serves as a core site for the group's small molecule manufacturing strategy. DSCP provides high-quality chemical synthesis and manufacturing services, supporting the global supply chain for blockbuster drugs such as loxoprofen and olmesartan. The Tatebayashi site is equipped with advanced technologies for complex chemical reactions and large-scale production under strict GMP compliance. As a key internal CMO, the company plays a vital role in ensuring the stable supply of essential medicines for the parent organization and its global partners.